|
|
| | DCL000409(XL184) Basic information |
| Product Name: | DCL000409(XL184) | | Synonyms: | DCL000409(XL184);N-(4-Fluorophenyl)-N'-[4-[[2-[[[2-(4-morpholinyl)ethyl]amino]carbonyl]-1H-pyrrolo[2,3-b]pyridin-4-yl]oxy]phenyl]-1,1-cyclopropanedicarboxamide;1,1-CyclopropanedicarboxaMide, N-(4-fluorophenyl)-N'-[4-[[2-[[[2-(4-Morpholinyl)ethyl]aMino]carbonyl]-1H-pyrrolo[2,3-b]pyridin-4-yl]oxy]phenyl]-;DCL000409;CS-938;N-(4-fluorophenyl)-N-(4-((2-((2-morpholinoethyl)carbamoyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy)phenyl)cyclopropane-1,1-dicarboxamide;1-Cyclopropanedicarboxamide;3-b]pyridin-4-yl]oxy]phenyl]- | | CAS: | 1021950-26-4 | | MF: | C31H31FN6O5 | | MW: | 586.61 | | EINECS: | | | Product Categories: | | | Mol File: | 1021950-26-4.mol |  |
| | DCL000409(XL184) Chemical Properties |
| density | 1.428 | | storage temp. | Store at -20°C | | solubility | DMSO: ≥ 46 mg/mL (78.42 mM) | | pka | 12.22±0.40(Predicted) | | form | Powder |
| | DCL000409(XL184) Usage And Synthesis |
| Uses | N-?(4-?Fluorophenyl)?-?N''-?[4-?[[2-?[[[2-?(4-?morpholinyl)?ethyl]?amino]?carbonyl]?-?1H-?pyrrolo[2,?3-?b]?pyridin-?4-?yl]?oxy]?phenyl]?-1,?1-?cyclopropanedicarbox?amide is a tyrosine kinase inhibitor used in combination with fragmenting aromatic nitrogen compounds as antiproliferative agents. |
| | DCL000409(XL184) Preparation Products And Raw materials |
|